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Abstract
Objective: The aim of this study was to evaluate the expression of some 
non collagenous extracellular matrix proteins, in particular tenascin, in human 
placentas of intrauterine growth restricted fetuses with abnormal umbilical 
Doppler velocimetry.
Study Design: Study group (group A) consisted of 23 pregnant women 
with intrauterine growth restricted fetuses, with or without preeclampsia. Control 
group (group B) consisted of 10 pregnant women with appropriate fetal weight 
for gestational age. Placental specimens were collected from biopsies obtained 
after cesarean delivery. Umbilical artery Doppler velocimetry was performed 
within four hours from delivery in all patients. Tenascin expression was studied 
by immunohistochemistry and western blot techniques. 
Results: A difference in birth weight and placental weight was found in the 
two groups, being lower in the study group. Umbilical artery Doppler velocimetry 
showed abnormal patterns in the study group and normal findings in the control 
one. Tenascin was strongly expressed in placentas from growth restricted 
fetuses, as shown by immunohistochemistry and by RT-PCR, while it was 
almost absent in placentas from group B.
Conclusion: A relationship between abnormal Doppler patterns and tenascin 
distribution in growth restricted fetuses has been observed. The presence of 
tenascin might be considered as a placental compensatory mechanism in FGR 
fetuses with abnormal umbilical artery Doppler velocimetry.
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Extracellular Matrix
levels of placental oxidative stress lead to PE and FGR, and placental 
hypoxia-reoxygenation is a potential cause of such stress. High levels 
of Reactive Oxygen Species (ROS) may induce cellular apoptosis. 
Thus, ROS-scavenging enzymes, such as Superoxide Dismutase 
(SOD) enzyme family, are important for preserving fetal growth [6]. 
Several placental histological and morphological abnormalities such as 
infarcts, terminal villous fibrosis and impaired trophoblastic invasion 
have been well described in FGR placentas [7-10]. Many studies have 
reported an association between abnormal Doppler velocimetry 
changes in umbilical artery and adverse perinatal outcome in growth 
restricted fetuses. The correlation between placental morphology 
and umbilical artery Doppler velocimetry, an indicator of placental 
vascular resistance, shows that substantial changes in the growth of 
villi and in fetal vasculature can reduce maternal-fetal exchanges of 
nutrients and oxygen and contribute to fetal hypoxic stress [11].
The human placenta, as a boundary organ between mother and 
fetus, plays a dynamic role in establishing and maintaining pregnancy 
through a multifunctional way involving continuous rearrangement 
in its structure. It is now widely accepted that the Extracellular Matrix 
(ECM) is a dynamic and highly specialized structure, involved in 
several signal transduction pathways [12]. For instance, ECM proteins 
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Introduction
Fetal Growth Restricted (FGR) fetuses are the fetuses in which 
growth restriction implies a pathological restriction of the genetic 
growth potential. As a result, FGR fetuses manifest evidence of 
fetal compromise i.e. abnormal Doppler velocimetry [1]. FGR with 
or without Preeclampsia (PE) complicates a significant number 
of pregnancies [2,3]. This condition is an important risk factor 
for adverse perinatal outcome and contributes to maternal and 
perinatal morbidity and mortality. Impaired placental perfusion 
and angiogenesis seem to be the most common causes of FGR, 
even if, in some cases, both FGR and PE are related to a failure of 
immunomodulatory placental functions [4,5]. Moreover, excessive 
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are degraded by Matrix Metalloproteinases (MMPs), endopeptidase 
capable of processing a number of bioactive molecules. They are 
released by placental cells during tissue remodeling processes, cell 
migration and neoangiogenesis: aberrations in MMPs activity in 
early pregnancy can play a role in the physiopathology of conditions 
like FGR [13]. It has been recently suggested that ECM proteins, 
such as fibronectin, tenascin and laminin, play different roles in cell 
proliferation, migration and differentiation. Tenascin, in particular, 
has shown to be able in modulating cellular adhesion by increasing 
or decreasing it, and seems to be involved in the immunological 
protection of the embryo during implantation. Moreover, tenascin 
seems to be involved in villous repairing after placental infarctions 
and in neoangiogenic mechanisms [14,15]. Also fibronectin, which 
often co-distributes with tenascin, and laminin, can induce migration 
of cell populations and metabolites [16]. Cell–matrix interactions 
represent a so important phenomenon that we can hypothesize 
that some changes in the structure and in the distribution of these 
proteins are involved in pregnancies complicated by FGR. Moreover, 
tenascin, whose expression has been correlated with villous growth, 
cells proliferation and fibrinoid deposition, may play a critical role 
in placental homeostasis development throughout pregnancy [14]. 
Tenascin is a large ECM glycoprotein. Until now five isoforms are 
known: tenascin-C, or cytotactin, which plays a regulatory role on 
neuron morphology and adhesion, representing the most abundant 
form [17], tenascin-X, whose gene is on chromosome 6 and is 
typically detected in muscles, tenascin-Y distributed on muscle-
tendon junctions, tenascin-J or janusin, exclusive of the nervous 
tissue and tenascin-R which is synthesized by oligodendrocytes 
during mielinization [18]. 
Tenascin-C is mostly expressed in the mesenchymal villi, cell 
islands and columns. These structures are the proliferating units of 
the villous trees. Probably this molecule is involved in angiogenesis. 
In addition, tenascin separates fibrinoid deposits at the surface of the 
villous trees from the fetal stroma. This location suggests a role of such 
protein in placental repair mechanisms and in immunoprotection of 
fetal tissues [19].
In the present study we have investigated the placental expression 
of non collage nous ECM components such as fibronectin and 
tenascins in pregnancies complicated by FGR with or without PE, 
with abnormal umbilical artery Doppler findings. Our attention was 
particularly appointed on the expression of tenascin-C, as this protein 
is involved in various aspects of cell and tissue development and in 
cell-to-cell and cell-to-substrate adhesion.
Our study includes a control group of healthy pregnancies with 
appropriate fetal gestational age and normal umbilical artery Doppler 
waveforms. 
Patients and Methods
Patients
A number of 33 Caucasian pregnant women were recruited 
between January 2010 and December 2013. On the total, 23 patients 
affected by FGR, with or without PE, were considered for the study 
group (group A). All patients of the group A were submitted to 
cesarean section. The control group (group B) consisted of 10 
pregnant women with appropriate fetal growth, homogeneous for 
age, BMI (20-25 kg/m2), socioeconomic status and gestational age 
to the group A (Table 1). In the group B, abnormal presentation 
and previous cesarean section were the indications for cesarean 
section. Gestational age was calculated using the crown-rump length 
ultrasonographic determination in the first trimester, according to 
the last menstrual period. Ultrasound criteria were applied to assess 
fetal growth. Fetuses were considered Appropriate for Gestational 
Age (AGA) if Abdominal Circumference (AC) was found between 
10th and 95th percentile. Fetuses were considered affected by FGR, 
if abdominal circumference was found below the 10th percentile of 
our standard population fetal growth curves. At delivery, neonates 
were consisted Low Birth Weight (LBW) if neonatal weight was less 
than 2,500 g and Very Low Birth Weight (VLBW) if less than 1,500 g.
PE complicated 11 cases out of 23 of the group A. At delivery, 
placental tissue was collected with the permission of the local 
research, Ethics Committee and with the informed consent of all 
patients. Clinical characteristics of the two groups were compared by 
the one-way ANOVA test. 
Doppler evaluation
The Doppler evaluation of umbilical artery resistance was 
performed within four hours from delivery in both groups. Doppler 
signals were obtained using an Echo Color Doppler Samsung 
Medison A30 and an Echo Color Doppler Samsung WS80 combined 
with a 3.5 MHz convex probe. The Doppler sample volume was 
placed on a free-floating tract of the umbilical cord during fetal quiet 
status. A near zero insonation angle was obtained for every Doppler 
examination. To analyze the Doppler flow velocity waveforms, 
the Pulsatility Index (PI) was automatically calculated (maximum 
velocity–minimum velocity/mean velocity) and the average of three 
consecutive measurements was used for analysis to minimize intra-
observer variability. Doppler findings were considered as mild if PI 
values were above the 2SD of the mean for gestational age based 
reference standards, moderate when the End-Diastolic Flow Was 
Absent (AEDF), severe when the End Diastolic Flow was Reversed 
(REDF). All measurements were performed by a single experienced 
investigator (G. N.) to minimize inter-observer variability.
Immunohistochemistry
Normal and pathological placental tissue samples were randomly 
harvested from both maternal and fetal side. Specimens were fixed 
and embedded in paraffin or cryopreserved at – 80°C. 5 μm-thick 
FGR (group A) AGA  (group B) p
Number of cases 23 10
Age (media +/- DS) 28.8+/−4 21.2 +/− 5 0,525
Parity 0.6+/− 0.3 0.4+/− 0.2 0.338
G. A. (delivery) 35+/− 3.3 36.1+/− 2.1 0.003
Birth weight (g) 1680+/− 530 3002+/− 420 <0.001
Placental weight (g) 298+/− 84 480+/− 95 <0.001
Pre-eclampsia (n) 11/21 -
Perinatal morbidity (n) 20 - <0.001
PI > 2 DS (n/%) 9/% - <0.001
ARED (n/%) 12/% - <0.001
Table 1: Clinical Features of Group A (FGR) and group B (AGA).
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serial sections were cut, mounted on slides, and immunostained 
for Tenascin (Sigma, St. Louis, MO, USA, mouse monoclonal 
IgG) and Fibronectin (Sigma, rabbit polyclonal IgG) as previously 
described [20]. Briefly, immunohistochemistry was performed with 
indirect immunofluorescence technique: sections were incubated 
for 30 minutes with 10% serum derived from the species in which 
the secondary antibody was raised, and subsequently with primary 
antibody for 60 minutes at 37oC. After PBS washes, slides were 
incubated with rhodamine or fluoresce in conjugated anti-rabbit 
or anti-mouse IgG antibody for 60 minutes at 37oC. Nuclei were 
labeled with DAPI for 15 minutes at room temperature before the 
final washes in PBS and sections were then mounted in Vectashield. 
Signal was visualized with a Leica DMLB fluorescence microscope. 
Negative controls were included for each staining using an isotype-
matched non-specific antibody. Microscopic analysis was performed 
by three independent observers, using a four point arbitrary scale 
ranging from 0 (total absence of immunopositivity) to 3 (very strong 
immunopositivity), and pictures were taken with digital camera 
connected to the microscope (Leica DC200).
RT-PCR
RT-PCR was used to analyze target gene expression in the present 
study. Total RNA was isolated by lysing frozen tissue samples (150-
300 mg) in Trizol solution (Life Technologies, GIBCO BRL) according 
to the supplier’s protocol. RNA was precipitated and quantified 
by spectroscopy. 1 µg of total RNA of each sample was reversely 
transcribed using the First-Strand cDNA Synthesis Kit (Amersham 
Pharmacia Biotech) according to the protocol supplied by the 
manufacturer. The random hexamer primers provided in the kit were 
used. The same cDNA product obtained from each sample was used 
for subsequent PCR amplification with the primer sets prepared for 
the target gene and GAPDH housekeeping gene. The amplification 
of the GAPDH gene was used as double internal control. The ratio 
between the samples and the housekeeping gene was calculated to 
normalize for initial variations in sample concentration and as a 
control for reaction efficiency. Primer sequences were designed using 
the software Primer 3 (developed by Steve Rozen, Helen J Skaletsky) 
available on-line at http://www-genome.wi.mit.edu. Semiquantitative 
Polymerase Chain Reaction (PCR) was performed using the following 
conditions: 95°C, 5 min initial denaturing phase; 95°C, 1 min; 55°C, 
1 min; 72°C, 1 min for 35 cycles; 72°C, 10 min, final extension. The 
reaction was carried out in a total volume of 50 ml containing 3 µl of 
cDNA, 10-20 pmol of each primer, 200 mM each of dNTP, 1.5 mM 
MgCl2 and 1 unit of Taq polymerase with the reaction buffer supplied 
with the kit. In each experiment, possible DNA contamination was 
determined by a control reaction in which cDNA was omitted from 
the reaction mixture and replaced by DNAse and RNAse free water. 
Figure 1: Normal umbilical artery Doppler pattern in the control group (a); increased umbilical artery PI values above 2DS in LBW fetuses (b); AEDF (c) and REDF 
(d) in VLBW fetuses.
Figure 2: Tenascin (red fluorescence) and fibronectin (green fluorescence) 
distribution in control (left) and FGR (right) placentas. Nuclei are 
counterstained with DAPI (blue fluorescence).
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The amplified products (12 µl of each sample) were analyzed by 
electrophoresis in a 2% agarose gel containing ethidium bromide, 
followed by photography under ultraviolet illumination. The levels 
of mRNA were estimated by densitometric scanning and normalized 
against GAPDH loading controls. Densitometric analyses of the PCR 
products were performed using the ImageJ v1.29 software (developed 
by Wayne Rasband) available on-line at http://rsb.info.nih.gov/ij/. 
All PCR products were purified using QIAquick PCR purification 
kit (Qiagen, Santa Clarita, CA, USA) and their identities verified by 
automated DNA forward and reverse sequencing using adideoxy 
terminator reaction chemistry for sequence analysis on the Applied 
biosystem Model 373A DNA sequence.
Results
Patients
Clinical characteristics of the two groups are shown in Table 
1. No difference for age, parity and gestational age at delivery was 
found between the two groups. Both neonatal and placental weight 
were lower in the study group than in the control group (p<0.001). 
Increased perinatal morbidity was observed in the study group 
(p<0.001). Group A babies were further divided in two groups 
according to birth weight: 10 LBW and 13 VLBW neonates were 
found. PE was detected in 5 out of 10 pregnancies with LBW infant 
and in 6 out of 13 pregnancies with VLBW infant.
Doppler evaluation
Normal umbilical artery Doppler pattern was found in the control 
group (Figure 1a). Increased umbilical artery PI values above 2DS for 
our normal curves were found in all LBW fetuses (Figure 1b); AEDF 
(Figure 1c) or REDF (Figure 1d) were detected in all VLBW fetuses. 
Immunohistochemistry
Fibronectin showed a normal distribution without significant 
differences between control and FGR placentas, with or without 
Doppler anomalies. Immunopositivity for Tenascin was very weak 
in healthy placentas (Figure 2), when compared with the FGR ones, 
where Tenascin was strongly expressed in both maternal and fetal 
side, with a mosaic-like pattern of distribution. To better relate 
Doppler findings with immunohistochemistry, Tables 2A and 2B 
show the Immunohistochemical and Doppler findings in the study 
group. Table 2A, in particular, regards low birth weight FGR. Table 
3 shows Immunohistochemical observations as well as Doppler 
findings in the control group with appropriate birth weight (AGA).
RT- PCR
RT-PCR analysis allowed the comparison between the two groups 
of patients in terms of tenascin synthesis (Figure 3). Tenascin-C and 
Cases Birth weight AG FGR FGR+PE Tenascin Fibronectin Velocimetry Doppler
DCB LBW III trimester • +++ ++ P.I.> 2 DS
GC LBW III trimester • ++ + P.I.> 2 DS
MM LBW III trimester • +++ + P.I.> 2 DS
LM LBW III trimester • +++ ++ P.I.> 2 DS
MR LBW III trimester • ++/+++ + P.I.> 2 DS
AL LBW III trimester • ++/+++ + P.I.> 2 DS
RA LBW III trimester • +++ + P.I.> 2 DS
AT LBW III trimester • ++ + P.I.> 2 DS
TF LBW III trimester • +++ + P.I. >2 DS
LP LBW III trimester • ++/+++ + P.I. >2 DS
Table 2A: Perinatal outcome, Doppler velocimetry and Immunohistochemical features in LBW (Group A) fetuses.
Cases Birth weight AG FGR FGR+PE Tenascin Fibronectin Velocimetry Doppler
PL VLBW III trimester • +/- ++ A.R.E.D
MS VLBW III trimester • + ++ A.R.E.D.
GM VLBW III trimester • +/- +++ A.R.E.D.
LN VLBW III trimester • + ++ A.R.E.D.
AS VLBW III trimester • ++ ++ A.R.E.D.
DF VLBW III trimester • - ++ A.R.E.D.
SB VLBW III trimester • ++ ++ A.R.E.D.
AR VLBW III trimester • +/- ++ A.R.E.D.
RF VLBW III trimester • +/- ++ A.R.E.D.
MA VLBW III trimester • +/- + A.R.E.D.
LT VLBW III trimester • + ++ A.R.E.D.
GG VLBW III trimester • +/- + A.R.E.D.
LC VLBW III trimester • + ++ A.R.E.D.
Table 2B: Perinatal outcome, Doppler velocimetry and immunohistochemical features in VLBW fetuses (Group A).
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tenascin-X were low in placentas from the control group, while they 
were synthesized in all the placental specimens from the group A. 
The expression of tenascin subunits was not affected by individual 
variability in pathological specimens, but it is reasonable that its 
amount might be related to different gestational age.
Discussion
Placentation requires extensive vasculogenesis and subsequent 
angiogenesis with deep ECM involvement in tissue remodeling. 
Impaired placental perfusion and angiogenesis, resulting in placental 
pathology, are considered the most important causes of FGR [4,5]. 
According to umbilical Doppler analyses, FGR fetuses have been 
subdivided in groups of progressive severity [21]. Correlations 
between acid-base balance and Doppler findings show that only the 
most severe FGR fetuses have impaired oxygenation and acid-base 
balance [22]. 
Many studies documented severe histological and morphological 
abnormalities in placentas of affected fetuses [7,8,23,24]. In a 
previous investigation, we approached some factors involved in the 
balance between the oxidative stress and the expression of molecules 
preventing and/or protecting tissues, like SOD, MMP-2 and MMP-9, 
and some receptors for angiogenic factors, i.e. Vascular Endothelial 
Growth Factor Receptor (VEGFR)-2 and angiopoietin-1 receptor. 
We found that extracellular SOD, the main anti-oxidant enzyme in 
vascular wall, was significantly reduced in FGR placentas. As regards 
angiogenesis, we observed an increased expression of VEGFR-2 
(early marker of neoangiogenesis) and a reduction of angiopoietin-1 
receptor (marker of mature vessels) in FGR placentas. Moreover, 
MMP-2 and MMP-9 were constantly reduced in IUGR placentas. 
We hypothesized that oxygen levels affect ECM remodeling by MMP 
and neoangiogenesis as a consequence [25]. In another earlier study, 
we found extracellular matrix abnormalities more evident in fetuses 
affected by FGR with AEDF or REDF in umbilical artery [22]. These 
findings prompted us to hypothesize that the ECM structure plays 
a critical role in umbilical artery Doppler velocimetry regulation. 
An increased ECM stiffness and the consequential changes in the 
pressure gradient between fetus and placenta may exert an effect 
on the development of FGR and on the onset of abnormalities in 
Doppler findings in umbilical artery. Tenascin is poorly expressed 
in adult normal tissues, but it is involved in many wound repair 
mechanisms [14], being a peculiar ECM component mainly 
expressed during embryonic and tumor growth, but weakly in term 
placenta. In human placenta tenascin is expressed in a mosaic-like 
Figure 3: Expression of tenascin as measured by RT-PCR.
way in the mesenchymal villi, cell islands and cell columns during the 
developmental placental stages [26].
Castellucci et al. [14,19] have investigated the expression of 
this molecule in the placenta as related to epitelial-mesenchymal 
interaction, cells proliferation and fibrin deposition. It is particularly 
interesting to study its expression and its distribution inside an organ 
like placenta, which has a very high metabolic activity and homes a lot 
of different cell population. In fact, some authors have hypothesized 
an immunomodulation and fetal protection function for tenascin; 
under this point of view, our observation that this protein strongly 
increases during PE supports the theory of a maternal immune 
system involvement in this kind of pathology. 
Indeed tenascin distribution through gestation seems to suggest 
that this molecule plays a pivotal role in placental development. Also a 
positive modulation of cell migration seems to be due to this protein: 
it is well known, in fact, that it is involved in the detachment of 
neoplastic cells during breast cancer and in other kinds of neoplasm, 
as tenascin rich basal lamina are easily crossed by cells and molecules 
[35]. All these functions are particularly and characteristically 
expressed during early Placentation, becoming progressively less 
evident with placental physiological ageing [28]. Since tenascin C and 
X immunopositivity is very low in term placenta, it was surprising 
that tenascin X was often highly expressed in FGR specimens we 
studied, with a “mosaic” distribution within placental tissue. 
Tenascin expression was more weak in the FGR fetuses with 
severe umbilical Doppler findings (ARED); on the contrary, it was 
very strong in the early gestation as well as in the FGR fetuses with 
moderate alteration in Doppler findings (PI> 2SD).
The presence of tenascin in the media of larger blood vessels of 
tumors and in capillary walls might be related with an angiogenic 
activity of this molecule, as improved tenascin-mediated angiogenesis 
and wound repair mechanism might be considered a compensatory 
mechanism in case of growth restriction with LBW.
The weak tenascin immunoreactivity in FGR fetuses with VLBW 
could be considered as a failed compensative mechanism of placental 
wound repair and angiogenesis.
Between the 28th and 32nd week of gestation, the reappearance of 
end diastolic flow in umbilical artery could lead to an improvement 
Cases Birth weight AG Tenascin Fibronectin VelocimetryDoppler
PL AGA III trimester + +++ Regular PI 
RT AGA III trimester +/- ++/+++ Regular PI 
MG AGA III trimester +/- ++/+++ Regular PI 
DA AGA III trimester + ++/+++ Regular PI 
MP AGA III trimester + +++ Regular PI 
GG AGA III trimester +/- ++ Regular PI 
SR AGA III trimester +/- +++ Regular PI 
ST AGA III trimester + ++ Regular PI 
TT AGA III trimester +/- ++/+++ Regular PI 
CA AGA III trimester + +++ Regular PI 
Table 3: Perinatal outcome, Doppler velocimetry and immunohistochemical 
features (Group B).
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of abnormal umbilical artery velocimetry with less severe FGR, or to 
a persistent ARED flow that lead to the most severe FGR associated 
with abnormal umbilical artery Doppler velocimetry [29-31]. It is 
highly suggestive that these fluctuating values depend on wound 
repair mechanisms which operate during placental development. 
Conclusion
Based on our results, strong tenascin immunoreactivity could be 
considered as a marker of improved wound repair and angiogenesis 
in these FGR fetuses with better perinatal outcome. Finally, impaired 
umbilical artery Doppler velocimetry with persistence of end 
diastolic flow would be possible when the wound repair mechanism 
in placental tissue does not fail. An ongoing study has been settled to 
verify if tenascin or related metabolites can be sampled in cervico-
vaginal fluid. On these bases, tenascin could be a tailor biomarker 
of placental angiogenesis in FGR fetuses who have the possibility to 
respond to chronic hypoxia due to placental insufficiency.
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